We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
+1.58%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$251M
AUM Growth
-$32.1M
Cap. Flow
-$32.3M
Cap. Flow %
-12.88%
Top 10 Hldgs %
68.46%
Holding
112
New
6
Increased
15
Reduced
10
Closed
13

Top Buys

Rank Stock Value
1
DCGO icon
DocGo
DCGO
+$3.77M
2
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$1.73M
3
VRNA
Verona Pharma
VRNA
+$1.28M
4
SNDX icon
Syndax Pharmaceuticals
SNDX
+$803K
5
MREO
Mereo BioPharma
MREO
+$667K

Top Sells

Rank Stock Value
1
FTAI icon
FTAI Aviation
FTAI
+$16.8M
2
WEST icon
Westrock Coffee
WEST
+$4.89M
3
CLOZ icon
Panagram BBB-B CLO ETF
CLOZ
+$4.73M
4
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$3.64M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$2.39M

Sector Composition

Rank Sector Weight
1 Healthcare 30.74%
2 Materials 28.51%
3 Financials 14.16%
4 Communication Services 8.23%
5 Technology 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQIX icon
101
Equinix
EQIX
$101B
– –
-37
Closed -$31K
FTAI icon
102
FTAI Aviation
FTAI
$21.3B
– –
-250,000
Closed -$16.8M
LULU icon
103
lululemon athletica
LULU
$13.2B
– –
-39
Closed -$15K
MDGL icon
104
Madrigal Pharmaceuticals
MDGL
$12.8B
– –
-3,584
Closed -$957K
SNY icon
105
Sanofi
SNY
$107B
– –
-45,000
Closed -$2.19M
WEST icon
106
Westrock Coffee
WEST
$749M
– –
-473,597
Closed -$4.89M
SYRS
107
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
– –
-233,000
Closed -$1.25M
FAZE
108
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
– –
-667
Closed -$8K
1 2 3 4
5

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
TT
TI-Trust Quincy, Illinois $168M AUM 24.32% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return

David M. Knott Jr's Q2 2024 Portfolio in Review

As of Q2 2024, David M. Knott Jr held 112 positions worth $251M, down 11% from $283M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

David M. Knott Jr withdrew a net $32.3M in Q2 2024, closing 13 positions and reducing 10 holdings. Its most notable exit was FTAI Aviation, an estimated $16.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 30% a quarter earlier, followed by Materials and Financials.

Against the trend, David M. Knott Jr opened a new position in BioCryst Pharmaceuticals worth $1.94M.

  • David M. Knott Jr's largest Q2 2024 buy was BioCryst Pharmaceuticals: 314,307 shares worth $1.94M.
  • David M. Knott Jr added most to DocGo in Q2 2024, an estimated $3.77M increase.
  • David M. Knott Jr's biggest Q2 2024 reduction was Panagram BBB-B CLO ETF, cutting an estimated $4.73M.
  • David M. Knott Jr fully exited FTAI Aviation in Q2 2024, selling an estimated $16.8M.
  • David M. Knott Jr's ten largest holdings make up 68% of its $251M portfolio in Q2 2024.
  • David M. Knott Jr opened 6 new positions and closed 13 in Q2 2024.
  • David M. Knott Jr's portfolio value fell 11% quarter-over-quarter to $251M.

Based on David M. Knott Jr's 13F filing for Q2 2024, filed 12 Aug 2024.